$14.4B
$137,000
0.0% of portfolio
1,009
Q2 2025
Reduced 88.54%
$721M
$12,000
0.0% of portfolio
5,678
Q2 2025
Added 88.01%
-
$133,000
0.0% of portfolio
-
Q2 2025
Reduced 18.78%
-
$1.05 Million
0.0% of portfolio
-
Q1 2025
Reduced 1.03%
$374M
$18,000
0.0% of portfolio
400
Q4 2024
New
Mfs Active Exchange Traded F
-
$14,000
0.0% of portfolio
-
Q1 2025
New
$259M
$14,000
0.0% of portfolio
1,556
Q2 2025
Added 1.63%
$0
$6,000
0.0% of portfolio
111
Q1 2025
Added 1,287.5%
$0
$216,000
0.0% of portfolio
3,609
Q1 2025
Reduced 0.3%
$654M
$69,000
0.0% of portfolio
16,965
Q2 2025
Added 685.05%
$1.47B
$252,000
0.0% of portfolio
4,568
Q2 2025
Added 60.45%
$27.4B
$994,000
0.0% of portfolio
15,747
Q2 2025
Reduced 36.8%
$8.94B
$658,000
0.0% of portfolio
16,183
Q2 2025
Added 26.63%
-
$3,000
0.0% of portfolio
-
Q2 2025
Reduced 73.64%
$3.68B
$73,000
0.0% of portfolio
537
Q2 2025
Added 65.74%
$6.71B
$1.17 Million
0.0% of portfolio
27,818
Q2 2025
Reduced 26.29%
$0
$13,000
0.0% of portfolio
254
Q2 2025
Added 1.2%
$10.4B
$497,000
0.0% of portfolio
1,667
Q2 2025
Reduced 68.59%
$145M
$105,000
0.0% of portfolio
7,457
Q2 2025
Added 564.62%
$0
$21,000
0.0% of portfolio
805
Q2 2025
Added 73.87%
$1.84B
$467,000
0.0% of portfolio
9,487
Q2 2025
Added 2.0%
$14B
$66,000
0.0% of portfolio
1,269
Q2 2025
Added 0.79%
$412M
$132,000
0.0% of portfolio
17,697
Q2 2025
Added 56.22%
$39.5B
$1.27 Million
0.0% of portfolio
1,732
Q2 2025
Reduced 28.84%
$504M
$174,000
0.0% of portfolio
11,665
Q2 2025
Added 280.34%
Corbus Pharmaceuticals Hldgs
-
$11,000
0.0% of portfolio
-
Q2 2025
Reduced 41.9%
$31.7B
$853,000
0.0% of portfolio
7,711
Q2 2025
Added 72.39%
$0
$76,000
0.0% of portfolio
1,124
Q2 2025
Added 253.46%
Neumora Therapeutics Inc.
-
$26,000
0.0% of portfolio
-
Q2 2025
Added 41.79%
$174M
$1,000
0.0% of portfolio
53
Q2 2025
Added 140.91%
-
$796,000
0.0% of portfolio
-
Q2 2025
Added 6.66%
$2.24B
$7,000
0.0% of portfolio
237
Q2 2025
Reduced 0.84%
$4.26B
$308,000
0.0% of portfolio
8,074
Q2 2025
Added 3.16%
$1.64B
$67,000
0.0% of portfolio
1,380
Q2 2025
Reduced 26.05%
$3.67B
$51,000
0.0% of portfolio
679
Q2 2025
Added 1.34%
$147B
$97,000
0.0% of portfolio
931
Q2 2025
Reduced 4.22%
$2.71B
$9,000
0.0% of portfolio
2,146
Q2 2025
Added 574.84%
$0
$24,000
0.0% of portfolio
491
Q2 2025
Added 29.89%
$134M
$1,000
0.0% of portfolio
56
Q2 2025
Added 100.0%
$90.5M
$5,000
0.0% of portfolio
70
Q3 2023
Reduced 62.16%
-
$81,000
0.0% of portfolio
-
Q2 2025
Added 37.66%
$292M
$2,000
0.0% of portfolio
474
Q2 2025
Reduced 21.78%
$332M
$8,000
0.0% of portfolio
1,120
Q2 2025
Added 1,434.25%
$14.1B
$1.17 Million
0.0% of portfolio
14,442
Q2 2025
Added 1.64%
$11.3B
$688,000
0.0% of portfolio
44,777
Q2 2025
Added 138.61%
$0
$1,000
0.0% of portfolio
20
Q2 2025
Reduced 80.95%
$4.97B
$79,000
0.0% of portfolio
938
Q2 2025
Added 5.75%
$0
$5,000
0.0% of portfolio
122
Q3 2023
Reduced 37.11%
$5.9B
$213,000
0.0% of portfolio
8,738
Q2 2025
Reduced 88.63%
$350M
$11,000
0.0% of portfolio
5,931
Q2 2025
Added 64.84%